Mushroom Toxicosis in Dogs and Cats: Amatoxin, Syndromic Triage, and Emergency Treatment

Bottom line

Triage suspected mushroom ingestion by time of onset, not species identification — visual ID is unreliable even for mycologists, and there is no proven antidote for any mushroom toxin [1]. The one you cannot miss is amatoxin (cyclopeptide) toxicosis from Amanita phalloides, A. ocreata ("death cap"/"destroying angel"), and some Galerina and Lepiota species: a deceptive biphasic course in which an early GI phase gives way to apparent recovery before fulminant hepatic (± renal) failure, with mortality of about 50% once liver failure develops [2]. Any patient whose GI signs begin 6 or more hours after a possible mushroom ingestion is amatoxin until proven otherwise — decontaminate aggressively, start hepatoprotection early, and call ASPCA APCC (888-426-4435) or Pet Poison Helpline (855-764-7661) [7].

Key facts

• Treat by syndrome and time-of-onset. History, latency to signs, and (when possible) ID drive the approach; with no proven antidotes, care is decontamination plus intensive supportive care [1].
• Short latency is usually the good news; long latency is the dangerous news. Rapid-onset GI-irritant, muscarinic, isoxazole, and psilocybin syndromes are largely self-limiting; the >6 h latent syndromes — amatoxin, hydrazine, and orellanine — are the organ-failure killers [1][2][4].
• Real-world lethality is low but real. In a retrospective of 421 Norwegian dogs the survival rate was 98.6%, with the 6 deaths following Amanita muscaria, Cortinarius rubellus, Amanita virosa, Clitocybe rivulosa, and Inocybe sp.; 64.4% were managed at home and 33.0% were hospitalized [6].
• Amatoxins inhibit RNA polymerase II, shutting down transcription and protein synthesis in the most rapidly dividing cells — hepatocytes, renal tubular epithelium, and intestinal crypt cells [2].
• Save the specimen. Preserve any recovered mushroom — wrapped in a damp paper towel inside a paper bag (not sealed plastic, which macerates it) — plus surrounding substrate; get expert spore-printing and ID in parallel while treating presumptively [7].

Toxic syndromes and time course

Because morphologic ID is impractical in the ER — the specimen is usually chewed, digested, or already bound to charcoal [1] — build your working diagnosis from latency to first clinical sign. The syndromic groups sort cleanly along that axis.

Syndrome (genera)	Toxin / mechanism	Onset	Target
Muscarinic (Inocybe, Clitocybe)	Muscarine, cholinergic	5–30 min, generally <2 h [3]	Autonomic NS
GI-irritant (Chlorophyllum, Russula, Paxillus)	Direct GI irritants	15 min–3 h [3]	GI
Psilocybin (Psilocybe)	Psilocybin/psilocin, serotonergic	0.5–1 h, rarely to 3 h [3]	CNS
Isoxazole (A. muscaria, A. pantherina)	Ibotenic acid → muscimol (GABA-A agonist)	30–120 min [3]	CNS
Cyclopeptide / amatoxin (A. phalloides, A. ocreata, Galerina, Lepiota)	Amanitins inhibit RNA pol II	6–24 h, rarely >24 h [2]	Liver → kidney
Hydrazine (Gyromitra)	Gyromitrin → monomethylhydrazine, depletes pyridoxal-5-phosphate	6–12 h [2]	CNS, liver
Nephrotoxic (Cortinarius)	Orellanine (paraquat-like)	3–20 days [4]	Kidney

The operational rule: GI signs that appear within the first hour or two usually herald a self-limiting course; GI signs delayed 6+ hours are a red flag for amatoxin or hydrazine, and a patient who is entirely well for the first 24 hours but presents days later with azotemia points to Cortinarius [1][2][4].

Amatoxin (cyclopeptide) toxicosis — the lethal one

Amanita phalloides is the mushroom most frequently implicated in fatal poisonings of humans and animals worldwide, and it is potent: caps contain roughly 1.5–2.3 mg of amanitins per gram of dried mushroom, so a single cap can carry a lethal dose [2]. The amatoxins (α-, β-, γ-amanitin) are rapidly absorbed, undergo enterohepatic recirculation (the rationale for repeated charcoal), and act by inhibiting RNA polymerase II — halting transcription and protein synthesis, with hepatocytes, renal tubular cells, and intestinal crypt cells hit hardest [2].

The clinical trap is the four-phase, biphasic course [2]:

1. Latent phase (6–12 h post-ingestion) — the animal appears normal.
2. GI phase (up to 24 h) — acute vomiting, diarrhea, abdominal pain, lethargy.
3. False-recovery phase (24–48 h) — GI signs abate and the patient looks better, which is the moment naive triage discharges a dying dog.
4. Hepatic/renal phase (36–72 h) — fulminant hepatic failure: rising liver enzymes, hyperbilirubinemia, coagulopathy, hepatic encephalopathy, and severe hypoglycemia from breakdown of hepatic glycogen, progressing to renal failure. Recovery or death (about 50%) follows over the next 7–14 days; puppies and high-dose ingestions can die within 24 hours [2].

The hepatocellular-failure picture overlaps the other classic canine hepatotoxins — keep sago palm (cycad) hepatotoxicosis and the profound hypoglycemia of xylitol toxicosis on the differential when a dog presents in acute liver failure without a witnessed mushroom.

Diagnosis and identification

Do not delay treatment for identification. Visual identification is difficult even for experienced mycologists, and treatment is driven by history and time-to-signs [1]. Practical steps [7]:

• Preserve evidence: any vomitus, recovered mushroom fragment, or a specimen from the ingestion site — wrapped in a damp paper towel inside a paper bag (never sealed plastic, which macerates it) — plus a sample of the substrate it grew on.
• Get expert ID in parallel, not first: spore printing and speciation require a mycologist (local university, or the North American Mycological Association).
• Confirmatory toxicology: urine amatoxin testing can confirm exposure — in the canine Santa Cruz case series, urine screening confirmed Amanita toxins in 4 of 5 dogs, with mycologist speciation in the fifth [5].
• Baseline and serial diagnostics for any >6 h presentation: liver enzymes and bilirubin, coagulation panel (PT/PTT), glucose, renal values and urinalysis, and electrolytes — trended through the deceptive false-recovery window [2].

Decontamination and treatment of amatoxin toxicosis

There is no antidote; the goal is to reduce toxin burden, interrupt enterohepatic recirculation, and support the liver through the transcriptional-arrest window [1][2]. All doses below are transcribed from their cited source; verify against Plumb's before administration and flag off-label use to the owner.

Decontamination

• Emesis only if ingestion is very recent and the patient is asymptomatic and neurologically intact.
• Activated charcoal 1–2 g/kg PO, with or without a cathartic such as sorbitol, followed by 2–3 half-doses within 24 hours to intercept enterohepatically recirculated amatoxin [2].

Supportive and hepatoprotective care [2]

• Aggressive IV crystalloid fluid therapy; correct and monitor for hypoglycemia with dextrose supplementation.
• Vitamin K1 and fresh frozen plasma / blood products for coagulopathy.
• Antiemesis: metoclopramide 0.2–0.4 mg/kg SC or IM q6h PRN, or maropitant 1 mg/kg SC q24h PRN.
• Silibinin 50 mg/kg IV at 5 hours and again at 24 hours after exposure. IV silibinin (silibinin dihemisuccinate / Legalon SIL) is the human standard of care but is access-limited and its veterinary use is off-label/investigational — where the IV form is unavailable, oral silymarin is a poor substitute (low bioavailability). Confirm formulation and availability.
• Penicillin G 1000 mg/kg IV at 5 hours after exposure — an OATP-blocking adjunct of uncertain benefit; confirm the regimen before use [2].
• N-acetylcysteine is a reasonable hepatoprotective adjunct (the same agent used in acetaminophen toxicosis); confirm the canine loading/maintenance dose in Plumb's. S-adenosylmethionine (SAMe) is commonly continued at discharge.

Advanced / referral-level care. As of 2026, the best-documented canine outcome data come from an adapted Santa Cruz protocol: a 5-dog case series in which all 5 dogs survived to discharge using core interventions of percutaneous biliary drainage, octreotide, and early nil-per-os, layered on decontamination and hepatoprotection [5]. This is a small series, not a controlled trial — but it establishes that survival is achievable with aggressive referral-level care and argues for early transfer of any confirmed amatoxin case to a facility that can provide it.

Stop/referral criteria. Rising bilirubin, worsening coagulopathy, refractory hypoglycemia, or encephalopathy signal the hepatic phase — escalate to intensive/referral care immediately; prognosis is grave once fulminant hepatic failure is established [2].

Other mushroom syndromes

Muscarinic (Inocybe, Clitocybe). Muscarine drives a cholinergic crisis — the SLUDDE picture (salivation, lacrimation, urination, diarrhea, dyspnea, emesis) with bradycardia, miosis, hypotension, and shock — beginning within 5–30 minutes [3]. This is the one syndrome with a true antidote: atropine 0.04 mg/kg, giving a portion IV and the remainder IM or SC, repeated as necessary; signs typically resolve within 30 minutes [3]. In the Norway series all 54 muscarinic-exposed dogs became symptomatic (hypersalivation 100%, vomiting 81.5%, diarrhea 79.6%, lethargy 68.5%), yet nearly all survived with prompt treatment [6].

Isoxazole (Amanita muscaria, A. pantherina). Ibotenic acid decarboxylates to muscimol, a GABA-A agonist, producing 30–120 minute onset of disorientation, opisthotonus, paresis, seizures, paddling, miosis, and alternating sedation/agitation, with recovery around 24 hours [3]. Treatment is supportive with seizure control — diazepam 0.5 mg/kg IV to effect (repeat as needed), phenobarbital 6 mg/kg IV, or pentobarbital 5–15 mg/kg IV [3]. Atropine is contraindicated here — the peripheral effects are anticholinergic, not cholinergic [3]. This is why "it's an Amanita" is not enough: A. muscaria and A. phalloides demand opposite management.

Hydrazine (Gyromitra, false morels). Gyromitrin hydrolyzes to monomethylhydrazine, which depletes pyridoxal-5-phosphate and lowers GABA, producing GI signs, convulsions, and coma 6–12 hours post-ingestion, then methemoglobinemia, hemolysis, and hepatorenal injury [2]. The syndrome-specific move is pyridoxine (vitamin B6) 75–150 mg/kg IV to control neurologic signs, plus activated charcoal 1–2 g/kg early and diazepam 0.5–1.0 mg/kg IV to effect for seizures [2].

Nephrotoxic (Cortinarius). Orellanine — structurally akin to the herbicides paraquat/diquat and undegraded by cooking, freezing, or drying — injures renal tubular epithelium. GI signs occur within 72 hours, but acute kidney injury is delayed 3–20 days, so decontamination is usually futile by presentation [4]. Care is supportive (IV fluids, GI protectants) with renal monitoring; complete recovery of renal function occurs in only ~30%, and chronic kidney disease is common [4].

GI-irritant ("backyard" mushrooms — Chlorophyllum molybdites, Russula, Paxillus). Self-limiting gastroenteritis (vomiting, ± bloody diarrhea, abdominal pain) at 15 minutes–3 hours, resolving in 6–24 hours; treat with IV fluids and GI protectants — sucralfate, famotidine, omeprazole, and antiemetics (maropitant, metoclopramide) [3]. In the Norway data, 61.3% (73/119) of GI-irritant exposures stayed asymptomatic and 35.3% (42/119) had only mild signs [6].

Hallucinogenic (Psilocybe). Psilocybin/psilocin cause agitation, ataxia, vocalization, nystagmus, hyperthermia, and occasionally seizures at 0.5–1 hour (rarely up to 3 h), usually resolving within 6 hours [3]. Care is supportive in a quiet environment; for seizures, diazepam 0.5–1 mg/kg IV or per rectum (incremental increase 5–10 mg, to effect) or phenobarbital 6 mg/kg IV/IM/PO q6h to effect, up to a maximum of 24 mg/kg total over 24 hours [3]. The CNS presentation overlaps other neuro-toxicants — keep cannabis toxicosis on the differential for the ataxic, disoriented dog.

Prognosis

Prognosis tracks the syndrome. The rapid-onset groups (GI-irritant, muscarinic, isoxazole, psilocybin) carry a fair-to-good outlook with decontamination and supportive care, and population data bear this out: 98.6% survival across 421 dogs [6]. The delayed-onset organ-failure syndromes are the exception — amatoxin toxicosis kills roughly half of patients once fulminant hepatic failure develops, often over 7–14 days [2], and orellanine leaves ~70% of Cortinarius survivors with residual renal dysfunction [4]. The practical determinant of amatoxin outcome is how early and aggressively you decontaminate and support the liver, ideally at a referral center capable of the interventions in the adapted Santa Cruz protocol [5].

Frequently Asked Questions

Which mushroom syndrome is most likely to kill a dog?

Amatoxin (cyclopeptide) toxicosis from Amanita phalloides, A. ocreata, and some Galerina and Lepiota species. The Merck Veterinary Manual reports mortality of about 50% once fulminant hepatic (± renal) failure develops, over 7–14 days, with puppies and high-dose ingestions dying within 24 hours. In a 421-dog Norwegian retrospective (Seljetun & Kragstad, 2023) overall survival was 98.6%, so most ingestions are survivable — but amatoxin, Cortinarius, and a few muscarinic/isoxazole cases account for the deaths.

Why does an amatoxin patient appear to recover before deteriorating?

Because the course is biphasic. Per the Merck Veterinary Manual, after a 6–12 hour latent phase and a GI phase (up to 24 h), there is a false-recovery phase at 24–48 hours when signs abate and the dog looks better — before the hepatic/renal phase at 36–72 hours. Discharging a patient during that false-recovery window is the classic fatal error; trend liver enzymes, coagulation, glucose, and renal values through it.

What is the atropine dose for muscarinic mushroom toxicosis?

The Merck Veterinary Manual gives atropine 0.04 mg/kg, administering a portion of the calculated dose IV and the remainder IM or SC, repeated as necessary; SLUDDE-type cholinergic signs (from Inocybe and Clitocybe muscarine) typically resolve within 30 minutes. Titrate to drying of secretions and resolution of bradycardia rather than to a fixed total.

Is atropine ever contraindicated in mushroom poisoning?

Yes. For isoxazole mushrooms — Amanita muscaria and A. pantherina — the Merck Veterinary Manual states atropine is contraindicated, because the peripheral effects are anticholinergic rather than cholinergic. This is why species matters within Amanita: A. muscaria (isoxazole, atropine-contraindicated, supportive care) and A. phalloides (amatoxin, hepatotoxic) are managed completely differently.

How do I decontaminate and start hepatoprotection for suspected amatoxin ingestion?

Per the Merck Veterinary Manual: activated charcoal 1–2 g/kg PO (± a sorbitol cathartic) followed by 2–3 half-doses within 24 hours to interrupt enterohepatic recirculation; silibinin 50 mg/kg IV at 5 and 24 hours after exposure; penicillin G 1000 mg/kg IV at 5 hours; plus IV fluids, dextrose for hypoglycemia, vitamin K1, and plasma for coagulopathy. Emesis only if very recent and asymptomatic. Confirm every dose in Plumb's and flag the off-label/access-limited status of IV silibinin.

How do I treat seizures from Gyromitra (false morel) ingestion?

Gyromitra's monomethylhydrazine depletes pyridoxal-5-phosphate, so the syndrome-specific antidote is pyridoxine (vitamin B6). The Merck Veterinary Manual gives pyridoxine 75–150 mg/kg IV to control the neurologic signs, with activated charcoal 1–2 g/kg early and diazepam 0.5–1.0 mg/kg IV to effect for seizures, alongside IV fluids and monitoring for methemoglobinemia and hemolysis.

Which mushroom causes delayed kidney failure, and how long is the lag?

Cortinarius species (orellanine). The Merck Veterinary Manual notes GI signs within 72 hours but acute kidney injury delayed 3–20 days after ingestion, which is why decontamination is usually futile by the time the dog is azotemic. Care is supportive with renal monitoring; complete recovery of renal function occurs in only about 30% of patients, and orellanine is not degraded by cooking, freezing, or drying.

Should I identify the mushroom before I start treatment?

No — treat by time of onset first. The Merck Veterinary Manual notes visual identification is difficult even for experienced mycologists, and there is no proven antidote, so management is decontamination plus supportive care guided by latency to signs. In parallel, per ASPCA APCC guidance, preserve any specimen (damp paper towel in a paper bag) plus substrate for spore printing, and call ASPCA APCC (888-426-4435) or Pet Poison Helpline (855-764-7661).